Home » Newsletters » BioWorld

BioWorld

Sep. 18, 1995

View Archived Issues

ISIS PHARMACEUTICALS, CIBA EXPAND ANTISENSE COLLABORATION

GI ACQUIRES REPLIGEN'S IMMUNE MODULATION PROGRAM

SENATE'S 1996 FDA BUDGET HOLDS THE LINE AT $189M

U.S., U.K. RESEARCHERS IDENTIFY LONG- SOUGHT ANTIGEN ON MEN-ONLY Y

NEXSTAR PHARMACEUTICALS, NEUREX JOIN CROWD AT EQUITY MARKETS

OTHER NEWS TO NOTE

COMBINATION THERAPY FOR AIDS PATIENTS WORKS BETTER THAN AZT ALONE

AGOURON PHARMACEUTICAL'S 3M-SHARE OFFERING WILL GROSS $84M